NEW YORK, Sept. 6 – In silico drug discovery company Entelos of Menlo Park, Calif., said Thursday it had raised $25 million in a private placement.

Bear Stearns Health Innoventures led the series C round of financing, while Earlybird, Equity4life, and Compaq Computer also invested in the round. Previous investors, including Abingworth Ventures, Boulder Ventures, Brentwood Ventures, Charles River Ventures, and St. Paul Ventures, also reinvested in the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.